logo
  • Offerings
  • Tools & Platforms
  • Markets
  • More

Sector: Pharmaceuticals & Biotechnology

|

Mid Cap

Senores Pharmaceuticals Share Price

Senores Pharmaceuticals Ltd.

1,160

49.05(4.42%)
25th May 2026 | 3:28 PM
NSE : SENORES
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Senores Pharmaceuticals Performance

Price Movement

₹1160.00

₹1115.35

₹1160.00

Today's LowToday's High

1 Year Performance

₹1160.00

₹500.00

₹1194.40

52 Week Low52 Week High

Markets Today

High₹1,160.00
Low₹1,115.35
Open at₹1,116.45
Prev Close₹1,110.95
Volumes2.69 L
Avg Price₹1,140.49
Lower Circuit₹888.80
Upper Circuit₹1,333.10

Historical Performance

3M High₹1,194.40
3M Low₹706.00
1 Yr High₹1,194.40
1 Yr Low₹499.55
3 Yr High₹1,194.40
3 Yr Low₹435.25
5 Yr High₹1,194.40
5 Yr Low₹435.25

Senores Pharmaceuticals Fundamentals

Market Cap
Above industry Median
4,990.80 Cr.
PE Ratio (TTM)
Above industry Median
43.30
Dividend Yield
0
Net Profit TTM
140.6% incr over last year
115.38
Net Profit Growth
140.6% incr over last year
115.38
PEG Ratio
Above industry Median
0.30
ROE
66.0% incr over last year
12.35
Operating Revenue TTM
649.50
Operating Revenue Growth
103.8% incr over last year
Book Value
Above industry Median
5.90
MFI
MFI Overbought
72.72
RSI
RSI is mid-range
65.15
EPS (TTM)
26.39
Debt to Equity
0.35
Face Value
10
Operating Profit Margin Qtr.
24.76
Operating Profit Qtr.
47.49
Net Profit Qtr.
31.61
Operating Revenue Qtr.
175.19
PB Ratio
5.90

Senores Pharmaceuticals Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Total Revenue36.8128.7635.3319.8211.86
Operating Expense40.2929.6933.8120.9714.60
Operating Profit-3.48-0.931.52-1.15-2.74
Depreciation4.133.583.651.881.27
Interest1.891.751.581.762.35
Tax4.210.871.220.900.88
Net Profit8.482.656.432.702.01

Senores Pharmaceuticals Technicals

Senores Pharmaceuticals Ltd. EMA & SMA

1160.00

103.45 (9.79%)

Bullish Moving Average

16

Bearish Moving Average

0

Day EMA5 ₹1040.6
Day EMA10 ₹1001.2
Day EMA12 ₹989.6
Day EMA20 ₹953.7
Day EMA26 ₹933.4
Day EMA50 ₹883.7
Day EMA100 ₹837.2
Day EMA200 ₹772.5

Senores Pharmaceuticals Support and Resistance

Resistance

First Resistance₹1107.28
Second Resistance₹1158.02
Third Resistance₹1186.03

Support

First Support₹1028.53
Second Support₹1000.52
Third Support₹949.78

Technical Indicators

Day RSI65.15
Day MFI72.72
Day ADX38.80
Day Commodity Channel Index200.90
William-43.51
Day MACD56.19
Day MACD Signal Line42.95
Day ATR55.21
Day ROC12533.28
Day ROC2118.20

Senores Pharmaceuticals Shareholding Pattern

Held ByDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoter45.845.845.845.845.845.8
FII4.24.23.74.33.43.6
DII11.89.69.58.69.39.7
Public38.240.44141.341.540.9

Senores Pharmaceuticals Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day2.14 L6.46 L33.15%
Week4.5 L17.89 L25.15%
1 Month2.35 L6.59 L35.58%
6 Month1.42 L3.32 L42.82%

Senores Pharmaceuticals SWOT Analysis

Strengths28
Weakness7
Opportunity6
Threats0

High DVM Mid and Small Caps (subscription)

Benjamin Graham Value Screen

Strong Performer, Getting Expensive (DVM)

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Strong Momentum: Price above short, medium and long term moving averages

Consistent high performing stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Companies with high TTM EPS Growth

Growth Stars: Strongest Annual EPS Performers

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Good quarterly growth in the recent results

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Effectively using its capital to generate profit - RoCE improving in last 2 years

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing Revenue every Quarter for the past 4 Quarters

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Stock gained more than 20% in one month

Highest Recovery from 52 Week Low

RSI indicating price strength

Top Gainers

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Senores Pharmaceuticals Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
No Record Found

Senores Pharmaceuticals Stock Comparison

Financials
Price (₹)₹1,681.10₹696₹943.35₹4,620₹521.20
% Change-0.21%3.36%-0.67%-2.43%0.22%
Revenue TTM (₹ Cr)₹1,403.18-₹1,598.19₹935₹4,359.02
Net Profit TTM (₹ Cr)₹185.12-₹206.20₹257.90₹255.19
PE TTM57.20-78.9043.4031.80
1 Year Return63.079.63103.31-2.21-6.77
ROCE31.5434.7834.76-11.40

FAQ's on SENORES

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy